Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Qualification of Working Standards – V 2.0

Posted on By

Analytical Method Development: SOP for Qualification of Working Standards – V 2.0

Standard Operating Procedure for Qualification of Working Standards in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/322/2025
Supersedes SOP/AMD/322/2022
Page No. Page 1 of 12
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

The purpose of this SOP is to define the procedure for the qualification of working standards (WS) used in analytical testing during method development, validation, and routine analysis. This includes preparation, characterization, documentation, and assignment

of expiration or requalification periods.

2. Scope

This procedure is applicable to all working standards prepared or procured for use in Analytical Method Development laboratories of the pharmaceutical organization, applicable for both API and finished product testing.

3. Responsibilities

  • Analytical Chemist: Responsible for preparation, qualification testing, and documentation of WS.
  • Standard Coordinator: Maintains the working standard inventory and coordinates analytical tests.
  • QA Reviewer: Reviews the qualification report and ensures compliance with predefined specifications and ICH guidelines.
See also  Analytical Method Development: Titrimetric Assay Development for Acidity - V 2.0

4. Accountability

The Head – Analytical Method Development is accountable for ensuring that all working standards are qualified, documented, and fit for purpose before use in any GMP-related testing.

5. Procedure

5.1 Receipt and Inspection

  1. Upon receipt, inspect the reference or bulk material for integrity, container labeling, and documentation such as CoA or MSDS.
  2. Ensure that the batch is from a GMP-compliant manufacturer or certified source.

5.2 Preparation of Working Standard

  1. Weigh accurately a pre-defined quantity of the bulk API or intermediate material in a clean, dry container.
  2. Homogenize thoroughly and divide into small aliquots (e.g., 100 mg to 1 g) depending on laboratory needs.
  3. Label each vial with WS ID, lot number, date of preparation, and assigned validity.

5.3 Qualification Tests

The following analytical tests shall be performed using a certified reference standard (CRS):

  1. Identification: Using IR, UV, or HPLC comparison with CRS.
  2. Assay (Purity): Not less than 98.5% and not more than 101.5% relative to CRS.
  3. Water Content: Using Karl Fischer titration if applicable.
  4. Residual Solvents: Using Headspace GC as per ICH Q3C guidelines.
  5. Melting Point / Boiling Point (if applicable)
  6. Any Specific Tests: As required by monograph or internal specification.
See also  Analytical Method Development: Water Content Method Development (Karl Fischer) - V 2.0

5.4 Data Evaluation and Documentation

  1. Compile all test results in the Working Standard Qualification Report (Annexure-1).
  2. Compare with acceptance criteria. Any deviation should be documented and investigated.
  3. Ensure at least three replicates for assay and ID testing.

5.5 Approval and Labeling

  1. Submit qualification report for QA review and sign-off.
  2. Upon approval, label vials with “QUALIFIED WORKING STANDARD”, WS code, potency, validity period, and analyst initials.
  3. Enter qualified WS into WS Inventory Register (Annexure-2).

5.6 Retention and Storage

  1. Store vials under specified conditions (e.g., 2–8°C, desiccated, protected from light).
  2. Retain a portion as a reserve sample until WS expiration or batch discontinuation.

5.7 Requalification or Disqualification

  1. Assign a requalification period (usually 6–12 months) based on stability or usage pattern.
  2. Re-test for ID and assay. If WS fails, discard and prepare new WS batch.
  3. Disposal of disqualified WS should follow SOP for hazardous waste (refer to SOP/AMD/321/2025).

6. Abbreviations

  • WS: Working Standard
  • CRS: Certified Reference Standard
  • QA: Quality Assurance
  • CoA: Certificate of Analysis

7. Documents

  1. Working Standard Qualification Report – Annexure-1
  2. WS Inventory Register – Annexure-2
See also  Analytical Method Development: Risk Assessment in Analytical Method Development - V 2.0

8. References

  • ICH Q6A – Specifications: Test Procedures and Acceptance Criteria
  • ICH Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • USP General Chapter <1058> on Analytical Instrument Qualification
  • 21 CFR Part 211 – Subpart I: Laboratory Controls

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Ritika Anand Ajay Thakur Dr. Harshita Goyal
Designation Analytical Chemist QA Reviewer Head – Analytical Method Development
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Working Standard Qualification Report

Test Parameter Result Limit Compliance
Identification (HPLC) Match with CRS Complies Yes
Assay 99.4% 98.5–101.5% Yes
Water Content 0.7% NMT 1.0% Yes
Residual Solvents Below limit Per ICH Q3C Yes

Annexure-2: WS Inventory Register

WS Code Name Batch No. Prepared On Expiry Status
WS-IBU-2025 Ibuprofen IBU-456 01/06/2025 01/06/2026 Qualified

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Expanded qualification tests and inventory structure Annual Review Dr. Harshita Goyal
01/07/2022 1.0 Initial release New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Elixir Department: SOP for pKa Determination – V 2.0
Next Post: Analytical Method Development: SOP for Calibration of UV-Visible Spectrophotometer – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version